These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8944589)

  • 1. Changing patterns of investigation and treatment of cardiac failure in hospital.
    Hillis GS; Al-Mohammad A; Wood M; Jennings KP
    Heart; 1996 Nov; 76(5):427-9. PubMed ID: 8944589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?
    Hillis GS; Trent RJ; Winton P; MacLeod AM; Jennings KP
    QJM; 1996 Feb; 89(2):145-50. PubMed ID: 8729556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors versus diuretics: when to choose which drug?
    Sharpe N
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):877-9. PubMed ID: 8011562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of echocardiograms in acute left ventricular failure.
    Morgan R; King D
    Postgrad Med J; 1995 Dec; 71(842):738-40. PubMed ID: 8552538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open access echocardiography in management of heart failure in the community.
    Francis CM; Caruana L; Kearney P; Love M; Sutherland GR; Starkey IR; Shaw TR; McMurray JJ
    BMJ; 1995 Mar; 310(6980):634-6. PubMed ID: 7503841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
    Arch Intern Med; 1997 May; 157(10):1103-8. PubMed ID: 9164376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of heart failure among older adults by office-based physicians in the United States.
    Croft JB; Giles WH; Roegner RH; Anda RF; Casper ML; Livengood JR
    J Fam Pract; 1997 Apr; 44(4):382-90. PubMed ID: 9108836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
    Davie AP; McMurray JJ
    Postgrad Med J; 1999 Apr; 75(882):219-2. PubMed ID: 10715761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice.
    Missouris CG; MacGregor GA
    Postgrad Med J; 1997 Jul; 73(861):409-11. PubMed ID: 9338025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
    Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
    McMurray JJ
    Eur Heart J; 1998 Oct; 19 Suppl L():L15-21. PubMed ID: 9821004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of inadequate investigation and treatment of patients with heart failure.
    Clarke KW; Gray D; Hampton JR
    Br Heart J; 1994 Jun; 71(6):584-7. PubMed ID: 8043344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
    McMurray JJ; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA;
    Lancet; 2003 Sep; 362(9386):767-71. PubMed ID: 13678869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-treatment mismatch in the pharmacotherapy of heart failure.
    Lee DS; Tu JV; Juurlink DN; Alter DA; Ko DT; Austin PC; Chong A; Stukel TA; Levy D; Laupacis A
    JAMA; 2005 Sep; 294(10):1240-7. PubMed ID: 16160132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences.
    Agvall B; Dahlström U
    Scand J Prim Health Care; 2001 Mar; 19(1):14-9. PubMed ID: 11303541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
    Ahmed A; Allman RM; DeLong JF; Bodner EV; Howard G
    South Med J; 2002 Jul; 95(7):703-10. PubMed ID: 12144075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimal treatment of chronic heart failure--with particular emphasis on angiotensin-converting enzyme (ACE) inhibitors].
    Haghfelt T
    Ugeskr Laeger; 1993 Oct; 155(41):3267-72. PubMed ID: 8256319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.